risankizumab,infliximab,certolizumab,golimumab,guselkumab,adalimumab,etanercept,bimekizumab,ustekinumab,ixekizumab,secukinumab
janssen,abbvie,ucb pharmaceuticals,eli lilly,boehringer ingelheim,amgen,novartis,pfizer
['etanercept', 'ustekinumab', 'guselkumab', 'adalimumab', 'ixekizumab', 'risan', 'secukinumab', 'bimekizumab', 'infliximab', 'golimumab', '#psa', 'certolizumab']
#psa eular guidelines consider #bdmard after *one* csdmard failure #bimekizumab not available yet #psoriaticarthritis #eular2023 
Rheumatologist | Physician |  Portsmouth Hospitals University NHS Trust UK | Views my own | Re-tweets do not mean endorsement | Mainly clinical news/updates